Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
124,470,870
-
Share change
-
-1,615,061
-
Total reported value
-
$31,994,071,856
-
Put/Call ratio
-
91%
-
Price per share
-
$257.01
-
Number of holders
-
954
-
Value change
-
-$470,206,356
-
Number of buys
-
403
-
Number of sells
-
456
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q3 2023
As of 30 Sep 2023,
BIOGEN INC. - COM (BIIB) was held by
954 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,470,870 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, Clearbridge Investments, LLC, and NORTHERN TRUST CORP.
This page lists
955
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.